Veriheal

JULY 16, 2020

The commission tasked with developing recommendations to improve mental health treatment for veterans concluded: Congress and the executive branch need to promote research into the therapeutic potential of cannabis and psychedelics such as psilocybin mushrooms and MDMA. Research is Limited Due to Many Obstacles.

Research and Development 81

Research and Development Clinical Trials Treatment Compliance 81

Cannabis Law Report

AUGUST 18, 2022

The laboratory researched the fine print of every state’s rules for hemp sampling, THC potency, cannabinoid content, residual solvents, pesticides, mycotoxins, heavy metals, and microbiology. With that research, they created elaborate matrices to compare each mandate. Source: [link].

Compliance 52

Compliance Compliance Hemp Research and Development 52

Cannabis Law Report

JULY 30, 2022

City and county governments may also refer ordinances with a sunset clause that essentially act as a temporary moratorium on psilocybin businesses to provide local governments the opportunity to develop time, place, and manner (TPM) restrictions. Contact Brett Mulligan at info@gl-lg.com or (503) 488-5424.

Business 52

Business Research and Development Compliance Compliance 52

Cannabis Law Report

DECEMBER 15, 2021

Benjamin Manufacturing Company to provide cultivation and processing facilities for psilocybin-containing mushrooms for authorized research purposes. market for research purposes is absolutely key for us as we look to expand our business in 2022,” he adds. The successful import by Mycrodose Therapeutics in the U.S.

Supply Chain 52

Supply Chain Research and Development DEA Pharmaceutical 52

MMJ Recs

MARCH 16, 2024

Economic Growth and Job Creation of the medical marijuana industry The medical cannabis sector serves as a catalyst for economic expansion and workforce development in regions where it’s legalized. Effective supply chain management encompasses inventory management, transportation logistics, and compliance with regulatory requirements.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Cannabis Law Report

JULY 24, 2021

Argel Aguilar-Valles at Carleton University (“Carleton”) Department of Neuroscience by the Accelerate program at Mitacs for research into the anxiolytic potential of TD-010 in preclinical models of chronic anxiety and depression. About BetterLife Pharma. BetterLife Pharma Inc. For further information, please visit www.abetterlifepharma.com.

Research and Development 98

Research and Development Treatment Therapy Media 98

Cannabis Law Report

JULY 28, 2021

InnarisBio), to develop a novel sol-gel intranasal drug delivery technology to improve treatments for mental health disorders. InnarisBio will collaborate with UniQuest, UQ’s Dr Parekh and his research team to formulate and develop bespoke sol-gel formulations for several psychedelic and non-psychedelic compounds nominated by InnarisBio.

Research and Development 98

Research and Development Programs Treatment Media 98

Cannabis Law Report

JULY 27, 2021

The initiative is part of Project Change Lives; Clever Leaves’ $25M product pledge to aid cannabis research in the U.S. The collaboration represents the Company’s first funded study with a research institution in the United States. organization to help advance scientific research into the potential medical benefits of cannabinoids.

Research and Development 98

Research and Development Pharmaceutical Sativa Extraction 98

WeedAdvisor

JULY 17, 2019

How, in a country with the most restrictive legal cannabis regulations, can such blatant non-compliance occur? There is also the possibility of accidental non-compliance – although Canada is yet to see this happen. This is where WeedAdvisor’s compliance solutions make a difference.

Compliance 56

Compliance Compliance Seed-To-Sale Research and Development 56

WeedAdvisor

JANUARY 2, 2019

One of the biggest advantages to legalization in Canada is the advantage of marijuana compliance. Despite the Canadian cannabis industry being in its infancy, marijuana compliance has already either failed to prevent defects (as was the case with Redecan) or was flatly ignored (the situation with Bonify). This applies on every level.

Compliance 53

Compliance Compliance Marijuana Research and Development 53

MMJ Recs

APRIL 30, 2024

A well-functioning supply chain ensures that medical marijuana products reach patients safely, efficiently, and in compliance with regulations. Supply chain management involves logistics, inventory control, quality assurance, and regulatory compliance. Continuous education and research are fundamental to cultivation best practices.

Cultivation 52

Cultivation Supply Chain Extraction Marijuana 52

Otherside Farms

MARCH 5, 2020

In fact, according to Grand View Research, the global legal marijuana market is expected to reach $146.4 Recently, the company was fined $75K by the state Cannabis Control Commission, marking the first fine issued by the newly developed regulatory agency. It’s time to get serious about compliance before it’s too late.

Compliance 52

Compliance Compliance Seed-To-Sale Cultivation 52

Cannabis Law Report

DECEMBER 9, 2021

MindMed presented FDA with a working Indications for Use statement (IFU), and a development roadmap. FDA provided key feedback regarding the draft IFU and the research methods that will lay the foundation for regulatory submissions. ” About MindMed.

Research and Development 52

Research and Development Clinical Trials Therapy Medicine 52

Cannabis Law Report

APRIL 17, 2022

billion) annually to state revenue, Minister for Development and Investment Adonis Georgiadis said, according to greekreporter.com. Tikun Europe was established in Greece in 2018 and is a subsidiary of the Israeli Tikun Olam global player in the research and development of medical cannabis products. billion euros ($1.67

Research and Development 52

Research and Development Chronic Pain Recreational Environment 52

Cannabis Law Report

NOVEMBER 11, 2021

Hartin served as Director of Compliance and Enforcement for the Oklahoma Medical Marijuana Authority, where she oversaw compliance for the state’s medical cannabis program and played an integral role in the OMMA’s legislative and regulatory processes. “She

Policy 97

Policy Research and Development Compliance Compliance 97

Cannabis Law Report

JULY 2, 2021

Cannabis magazine reports on the landlocked Pyrenees state developing its own medical cannabis industry. IRTA and Andorra Research and Innovation will define a model for the cultivation and industrial transformation of this plant in the country.

Research and Development 52

Research and Development Cultivation Extraction Medicine 52

MMJ Recs

APRIL 25, 2024

It encompasses several essential steps aimed at nurturing and optimizing plant growth and development: Seed Selection and Germination: The process begins with the careful selection of quality seeds, which are crucial for cultivating premium medical marijuana strains. Select seeds from reputable breeders known for producing stable genetics.

Marijuana 52

Marijuana Cultivation Safety Trichome 52

Cannabis Law Report

AUGUST 7, 2021

MAPS PBC catalyzes healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics. We are currently focused on developing MDMA-assisted therapy as a Breakthrough Therapy for PTSD, with plans to submit for FDA approval in 2023. Key Responsibilities.

Clinical Trials 105

Clinical Trials Research and Development Compliance Compliance 105

Cannabis Law Report

AUGUST 17, 2022

Ohio State Legal Studies Research Paper No. As a condition of safe harbor, require financial institutions to demonstrate compliance with anti-discrimination laws such as the Equal Credit Opportunity Act. Explicitly protect Minority Depository Institutions (MDIs) and Community Development Financial Institutions (CDFIs).

Banking 98

Banking Access Research and Development Compliance 98

Cannabis Law Report

SEPTEMBER 1, 2021

A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and alcoholic beverages. Looking to develop your career at the forefront of a rapidly expanding industry?

Research and Development 105

Research and Development Supply Chain Compliance Compliance 105

Veriheal

JANUARY 18, 2024

In a revolutionary development that reflects the ever-changing healthcare arena, cannabis nursing has earned official recognition as a specialized field in nursing. They recognize the growing interest and therapeutic applications of cannabis and its components, advocating passionately for comprehensive clinical research.

Education 113

Education Therapy Patients Research and Development 113

Cannabis Law Report

FEBRUARY 13, 2022

Reporting to a Program Specialist 3 (Cannabis), the Program Specialist 2 (Cannabis) positions will be responsible for overseeing and participating in inspecting, auditing, and performing a full range of compliance duties for the region assigned (Albany/Buffalo/NYC).

Programs 52

Programs Research and Development Seed-To-Sale Compliance 52

MMJ Recs

OCTOBER 26, 2023

It’s essential to be aware of the specific laws in your state to remain in compliance. Missouri : Missouri has a developing MMJ program, with a list of qualifying conditions and licensed dispensaries. Compliance with state laws and regulations is essential to avoid legal issues. Featured image by succo on Pixabay.

Law 98

Law Marijuana Programs Dispensary 98

MMJ Recs

FEBRUARY 21, 2024

Through an examination of existing research and anecdotal evidence, we aim to provide a closer look at the potential effects of medical marijuana on women’s health. Research suggests that cannabinoids may have anti-inflammatory and analgesic effects, potentially aiding in symptom relief.

Chronic Pain 105

Chronic Pain Marijuana Research and Development Cannabinoids 105

Cannabis Law Report

AUGUST 10, 2021

–(BUSINESS WIRE)– PSI Labs , an Ann Arbor, Michigan-based ISO 17025 accredited Safety Compliance Facility that provides essential cannabis testing services, today announced its expansion into Southern California with the acquisition of pH Solutions, LLC. Monrovia-Based Lab Acquisition Strengthens Cannabis Testing In California.

Research and Development 105

Research and Development Compliance Compliance Safety 105

Cannabis Law Report

JULY 23, 2021

Position Summary: Reporting to Operations Manager, the Cannabis & Controlled Substances Officer (CCBO) will inspect various teaching, diagnostic and research facilities of the University. Plans, schedules, and conducts inspections of teaching, diagnostic and research facilities at the University. Produces inspection reports.

Research and Development 105

Research and Development Safety Compliance Compliance 105

Cannabis Law Report

NOVEMBER 23, 2021

to provide naturally derived psilocybin for research and development of therapeutic products. “As the research and drug development work on psilocybin moves forward, HAVN Life continues to position itself as a supply chain leader, able to meet the demand for naturally derived psilocybin,” he adds.

Supply Chain 52

Supply Chain Research and Development Pharmaceutical Compliance 52

Cannabis Law Report

FEBRUARY 2, 2022

TAXMAP will be co-funded by the UK’s innovation agency, Innovate UK, in supplying a real-time tax and audit compliance solution for vice and e-commerce companies. Keeping track of invoices and tax compliance is more complicated than ever and there are no excise and tax solutions available for established and expanding cross border companies.

Compliance 52

Compliance Compliance Research and Development History 52

Cannabis Law Report

JUNE 25, 2021

Research Analyst. The Research Analyst, under the direction of the Director of Research, will provide quantitative data analysis and be responsible for managing, manipulating, analyzing, and modeling data for research reports and internal purposes. Career Opportunities. Deadline to apply: Friday, July 2, 2021 by 5 p.m.

Research and Development 105

Research and Development Compliance Compliance Data 105

Cannabis Law Report

AUGUST 3, 2022

The lack of robust research on cannabis products, cannabis as a therapy and dependence or addiction to cannabis heightens the challenge of developing sound policies on the use of cannabis in health care facilities. Food and Drug Administration. What are potential issues related to drug interactions, and potential side effects?

Research and Development 98

Research and Development Policy Patients Compliance 98

Cannabis Law Report

JUNE 29, 2021

In recent months, the DEA has issued a select number of licenses to several groups in the US to allow for the cultivation of Cannabis for scientific research purposes. BRC works with research groups studying Cannabis and Cannabis flower to understand the plant in a scientific and federally regulated environment.

Research and Development 102

Research and Development DEA Supply Chain Pharmaceutical 102

Medicinal Genomics

JULY 13, 2023

So here are just a dozen new developments, breakthroughs, and aha moments from this year’s summit that might just convince you to circle CannMed 24 on your calendar right now. the VP of Research & Development at Biopharmaceutical Research Company, Inc., But if you weren’t able to be there, you wouldn’t know that.

Research and Development 52

Research and Development Cannabinoids Medicine DEA 52

Cannabis Law Report

JUNE 2, 2022

27.350 of 2017 that set a regulatory framework for scientific and medicinal research of cannabis and approved its medicinal use in the Argentine Republic. The ARICCAME may create regional or provincial delegations to ensure swift and broad compliance with this new Law. The Law complements the act No. Source: JD Supra.

Medicine 52

Medicine Hemp Law Research and Development 52

SpeedWeed

APRIL 2, 2021

So, it’s been a long haul, most specifically just for the cannabis program to make sure that we were staying in compliance and doing it in a safe and sound way. There’s just so much compliance that has to happen on our end in order to protect the financial system as a whole, that it is more expensive.

Education 52

Education Banking Hemp Compliance 52

Cannabis Law Report

AUGUST 18, 2022

The firm’s deep expertise in pharmaceutical sciences, FDA regulatory compliance and pharmaceutical product liability litigation and risk management enables it to address complex legal hurdles faced by stakeholders seeking to research, develop, invest in and bring-to-market psychedelic therapies. BUFFALO, N.Y. , Aug.

Therapy 52

Therapy Research and Development Pharmaceutical Treatment 52

Cannabis Law Report

APRIL 18, 2019

This week, Kansas’ Governor signed Senate Substitute to House Bill 2167 , which expands the state’s hemp growth program from research to commercialization and ensures that hemp and hemp products are not considered controlled substances. Senate File 599 has passed the Senate and awaits House action.

Hemp 51

Hemp Media CBD Legislation 51

Cannabis Law Report

MAY 26, 2022

Identify and analyze legal issues and present clear recommendations to the CEO and executive team; the Position will report to the CEO, but will be expected to develop independent communication and relationships with the management team on a project level. Legal research needed by company. Proficient in research and writing.

Research and Development 52

Research and Development Compliance Compliance Policy 52